Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
aphasia
asymptomatic
ataxia
axonal degeneration
axonal transection
B cell lymphocytes
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
biologic markers
brain atrophy
brain volume
brainstem
brainstem, lesion of
carcinoma
carcinoma of breast
catatonia
central vein sign
cerebral cortex
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cervical spine
children
cigarette smoking
cognition
comorbidities
complications
controversies in neurology
conus medullaris, lesion of
cop 1
corproporphyrins
corpus callosum, lesion of
dementia
demyelinating disease
depression
diabetes insipidus
diagnostic criteria
differential diagnosis
disability rating scale, neurological
disability, neurological
efficacy
electroencephalogram
electroencephalogram, abnormalities of
epidemiology of neurology
Epstein-Barr virus
ethics in neurology
evoked potentials
extinction on double simultaneous stimulation
flu-like illness
fourth ventricle, shift of
gadolinium
gammaglobulin therapy, intravenous
hearing loss
hearing loss, sudden, unilateral
heralding manifestation
herpes virus
herpes virus infection
hydrocephalus
hydrocephalus, exvacuo
immunomodulation
immunosuppressive agents
infection
intellectual deficit
intellectual deterioration
interferon
interferon beta 1-a
interferon beta 1-b
intravenous
iron, brain
Kappa light chain biomarkers
laquinimod
leg weakness, unilateral
leukopenia
liver function enzymes
mania
manic-depressive
McDonald criteria for MS
memory, impairment of
mimics
misdiagnosis
mitoxantrone
MRI
MRI lesion location
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength
MRI, field strength, high
MRI, gradient-echo
MRI, incidental finding
MRI, lesion burden
MRI, negative
MRI, optic nerve
MRI, paramagnetic effect
MRI, serial
MRI, spinal cord
MRI, susceptibility weighted
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cognitive presenttion
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
neuropsychiatry
ocrelizumab
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, etiology of
optic neuritis, recurrent
optic neuritis, treatment of
optical coherence tomography
paramagnetic rim lesion, MR
periventricular leukomalacia
placebo
posterior fossa
posterior fossa, lesion of
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
protein 14-3-3, cerebrospinal fluid
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
radiculitis
radiculopathy
review article
risk factors
root lesion, nerve
rubeola virus
safety
seizure
seizure, children
seizure, non-treatment of
seizure, treatment of
seizure, treatment of, first
sensorineural hearing loss
serologic testing
spinal cord
spinal cord, cervical
spinal cord, lesion of
status epilepticus
steroid
steroid therapy, CNS treatment and complications with
symmetric brain lesions
symptomatic
tinnitus
treatment of neurologic disorder
ventricular enlargement
viral infection
viral infection, reactivation
visual evoked response
white matter disease
white matter disease, periventricular
workup
Showing articles 650 to 700 of 6327 << Previous Next >>

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Complete Ophthalmoplegia: An Unusual Sign of Bilateral Paramedian Midbrain-Thalamic Infarction
Stroke 39:1355-1357, Thurtell,M.J. &Halmagyi,M., 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Brain Magnetic Resonance Imaging Abnormalities in Neuromyelitis Optica
Acta Neurol Scand 118:218-225, Li, Y.,et al, 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Embolic Stroke Secondary to Cardiac Papillary Fibroelastoma
Neurologist 14:128-130, Zurru, M.C.,et al, 2008

Effect of Urgent Treatment of Transient Ischaemic Attack and Minor Stroke on Early Recurrent Stroke (EXPRESS Study): A Prospective Population-Baed Sequential Comparison
Lancet 370:1432-1442,1398, Rothwell,P.M., et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 69:1552-1553, Sorenson,P.S. &Bertolotto,A., 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Guidelines For Using Proton MR Spectroscopy in Multicenter Clinical MS Studies
Neurol 69:1942-1952, De Stefano,N.,et al, 2007

Long-Term Prognosis in Children With Neonatal Seizures: A Population-Based Study
Neurol 69:1816-1822, Ronen,G.M.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR 28:1639-1644, Ge,Y.,et al, 2007

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Balos Concentric Sclerosis Presenting as a Stroke-Like Syndrome
Nat Clin Pract Neurol 3:349-354, Mowry,E.M.,et al, 2007

Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007

Clinicopath Conf., Paraneoplastic Cerebellar Degeneration Due to Anti-Yo Antibodies From Breast Cancer
NEJM 356:612-620, Case 4-2007, 2007

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

Longitudinal Follow-Up of "Benign" Multiple Sclerosis at 20 Years
Neurol 68:496-500,480, Sayao,A-L.,et al, 2007

Gray Matter Involvement in Multiple Sclerosis
Neurol 68:634-642, Pirko,I.,et al, 2007

Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007

Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007

Clinicopath Conf., Left Atrial Myxoma with Systemic Embolization
NEJM 357:1137-1145, Case 28-2007, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Rehabilitation for Spatial Neglect Improves Test Performance But Not Disability
Stroke 38:2869-2870, Bowen,A. &Lincoln,N.B., 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Parental Transmission of MS in a Population-Based Canadian Cohort
Neurol 69:1208-1212,1202, Herrera,B.M.,et al, 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Predictors of Fitness to Drive in People With Parkinson Disease
Neurol 69:1434-1441, Devos,H.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Impact of Abnormal Diffusion-Weighted Imaging Results on Short-Term Outcome Following Transient Ischemic Attack
Arch Neurol 64:1105-1109,1080, Prabhakaran,S.,et al, 2007



Showing articles 650 to 700 of 6327 << Previous Next >>